TY  - JOUR
AV  - public
A1  - Malik, Farihah
A1  - Crichton, Siobhan
A1  - Plotnikova, Yulia
A1  - Latysheva, Inga
A1  - Samarina, Anna
A1  - Pokorska-?piewak, Maria
A1  - Gomez, Marisa Navarro
A1  - Bailey, Heather
A1  - Thorne, Claire
A1  - Judd, Ali
A1  - Turkova, Anna
A1  - Collins, Intira Jeannie
SN  - 0891-3668
N2  - We evaluated the effectiveness and safety of direct-acting antivirals in adolescents with hepatitis C (HCV)/HIV coinfection using pooled individual patient-level data from 5 European cohorts. Of 122 participants in follow-up from November 2013 to August 2021, 19 were treated <18 years of age; of 15 with HCV RNA available at/after 12 weeks post-treatment, all had sustained virologic response with acceptable safety. This evidence addresses an important gap in knowledge of treatment outcomes in adolescents with HCV/HIV coinfection in real-life settings.
KW  - Hepatitis C
KW  -  HIV
KW  -  treatment
KW  -  adolescents
KW  -  pediatric
KW  -  directacting antivirals
JF  - The Pediatric Infectious Disease Journal
PB  - Ovid Technologies (Wolters Kluwer Health)
ID  - discovery10186762
Y1  - 2024/02/02/
UR  - http://dx.doi.org/10.1097/inf.0000000000004271
TI  - Effectiveness and Safety of Direct-acting Antivirals for Treatment of Adolescents With HCV/HIV Coinfection: Real-world Data From Europe
N1  - © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.
This is an open-access article distributed under the terms of the Creative
Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBYNC-ND), where it is permissible to download and share the work provided it
is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
ER  -